| Literature DB >> 32932689 |
Xiaojing Hu1, Xing Li1, Yong Sheng1, Hengyu Wang1, Xiaobin Li1,2, Yixin Ou1, Zixin Deng1, Linquan Bai1, Qianjin Kang1.
Abstract
Actinosynnema species produce diverse natural products with important biological activities, which represent an important resource of antibiotic discovery. Advances in genome sequencing and bioinformatics tools have accelerated the exploration of the biosynthetic gene clusters (BGCs) encoding natural products. Herein, the completed BGCs of dnacin B1 were first discovered in two Actinosynnema pretiosum subsp. auranticum strains DSM 44131T (hereafter abbreviated as strain DSM 44131T) and X47 by comparative genome mining strategy. The BGC for dnacin B1 contains 41 ORFs and spans a 66.9 kb DNA region in strain DSM 44131T. Its involvement in dnacin B1 biosynthesis was identified through the deletion of a 9.7 kb region. Based on the functional gene analysis, we proposed the biosynthetic pathway for dnacin B1. Moreover, p-amino-phenylalanine (PAPA) unit was found to be the dnacin B1 precursor for the quinone moiety formation, and this was confirmed by heterologous expression of dinV, dinE and dinF in Escherichia coli. Furthermore, nine potential PAPA aminotransferases (APAT) from the genome of strain DSM 44131T were explored and expressed. Biochemical evaluation of their amino group transformation ability was carried out with p-amino-phenylpyruvic acid (PAPP) or PAPA as the substrate for the final product formation. Two of those, APAT4 and APAT9, displayed intriguing aminotransferase ability for the formation of PAPA. The proposed dnacin B1 biosynthetic machinery and PAPA biosynthetic investigations not only enriched the knowledge of tetrahydroisoquinoline (THIQ) biosynthesis, but also provided PAPA building blocks to generate their structurally unique homologues.Entities:
Keywords: Actinosynnema pretiosum; antitumor; biosynthetic gene cluster; comparative genomics; dnacin B1; p-aminophenylalanine
Mesh:
Substances:
Year: 2020 PMID: 32932689 PMCID: PMC7570522 DOI: 10.3390/molecules25184186
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The diversified biosynthetic gene clusters located in the chromosome of Actinosynnema strains (DSM 44131T, X47, ATCC 31280 and DSM 43827T). (A) The biological natural products discovered from the genus Actinosynnema. (B) Comparative genome sequence alignment among the Actinosynnema strains performed by MAUVE, indicating the variations in secondary metabolite-encoded biosynthetic gene clusters (BGCs) and discovering the BGC of dnacin B1 in the genome of strain DSM 44131T and strain X47. (C) Genetic organization of dnacin B1 BGC.
Figure 2Inactivation of dnacin B1 BGC. (A) Construction of the dnacin B1 BGC inactivation mutant by homologous recombination. (B) PCR validation of wild type and mutant HXJA01. When using din-val-F/R as primers, the product of mutant HXJA01 was 1507 bp, whereas there was no product in wild type. (C) PCR analysis of wild type and mutant HXJA01. When using din-in-F/R as primers, the product of wild type was 534 bp, whereas there was no product in mutant HXJA01. (D) HPLC-MS and bioassay analysis of wild type and mutant HXJA01. (E) HR-ESI-MS analysis result of the dnacin B1.
Deduced functions of ORFs in the dnacin B1 biosynthetic gene cluster.
| ORF | Number of | Proposed Function | Sequence Similarity (Protein, Origin) | % Identity/ | Accession No. |
|---|---|---|---|---|---|
|
| 951 | ABC transporter | IQ63_41860, | 64/75 | KND24720.1 |
|
| 117 | unknown | SD37_10880, | 55/75 | ANN21703.1 |
|
| 175 | protease inhibitor | AC230_04780, | 38/54 | KNB54254.1 |
|
| 395 | histidine kinase | A9W97_15640, | 51/60 | OBJ88517.1 |
|
| 159 | ATP-binding protein | RKT69099.1, | 45/51 | DFJ66_2293 |
|
| 306 | epimerase | DI639_00155, | 74/83 | PZO61411.1 |
|
| 228 | TetR family transcriptional regulator | STRAU_2618, | 58/71 | EPH44178.1 |
|
| 534 | flavin adenine dinucleotide (FAD)-linked oxidase | NapU, | 64/75 | AGD80628.1 |
|
| 471 | gamma-aminobutyraldehyde dehydrogenase | MCBG_02966, | 53/65 | EWM65833.1 |
|
| 741 | peptidase | NapG, | 48/56 | AGD80614.1 |
|
| 183 | flavin mononucleotide (FMN) reductase | SsuE, | 58/67 | WP_067345371.1 |
|
| 707 | regulatory protein | NapR3, | 55/68 | AGD80615.1 |
|
| 103 | 4-amino-4-deoxychorismate mutase | PapB, | 34/53 | BAD21142.1 |
|
| 307 | 4-amino-4-deoxyprephenate dehydrogenase | PapC, | 40/51 | BAD21141.1 |
|
| 300 | unknown | CLV43_102760, | 47/57 | PRY45195.1 |
|
| 796 | adenylation domain | NapH, | 51/60 | AGD80616.1 |
|
| 342 | non-heme iron hydroxylase | NapI, | 63/75 | AGD80617.1 |
|
| 1482 | NRPS | NapJ, | 68/79 | AGD80618.1 |
|
| C-A-PCP-RE | ||||
|
| 66 | MbtH-like protein | NapK, | 73/84 | AGD80619.1 |
|
| 1125 | NRPS | NapL, | 54/64 | AGD80620.1 |
|
| C-A-PCP | ||||
|
| 252 | thioesterase II | NapM, | 51/64 | AGD80621.1 |
|
| 632 | AMP-dependent synthetase and ligase | NapN, | 64/74 | AGD80622.1 |
|
| AL-PCP | ||||
|
| 3049 | NRPS | NapO, | 52/63 | AGD80623.1 |
|
| C-A-PCP | ||||
|
| C-A-PCP | ||||
|
| C-A-PCP | ||||
|
| 223 | hypothetical protein | NapP, | 45/59 | AGD80633.1 |
|
| 909 | ABC transporter | B0I31_10111, | 56/67 | PSL57800.1 |
|
| 280 | ABC transporter | CLV69_102810, | 53/69 | TDX97704.1 |
|
| 336 | 3-oxoacyl-synthase III (KS) | NapE, | 72/80 | AGD80612.1 |
|
| 754 | Transketolase | NapD, | 59/68 | AGD80611.1 |
|
| 76 | acyl carrier protein (ACP) | NapC, | 63/75 | AGD80633.1 |
|
| 306 | transketolase | NapB, | 68/77 | AGD80609.1 |
|
| 706 | 4-amino-4-deoxychorismate synthase | PapA, | 48/58 | BAD21140.1 |
|
| 486 | 4-hydroxyphenylacetate 3-monooxygenase | EWI31_24745, | 56/69 | TAI42134.1 |
|
| 613 | ABC transporter | CLV43_102777, | 70/78 | PRY45212.1 |
|
| 601 | ABC transporter | DIU55_13605, | 51/66 | PZN68908.1 |
|
| 477 | monooxygenase | NapA, | 69/76 | AGD80608.1 |
|
| 818 | UV-repair protein | NapR1, | 75/84 | AGD80606.1 |
|
| 244 | methyltransferase | QncJ, | 47/65 | AGD95052.1 |
|
| 118 | long-chain-fatty-acid--CoA ligase | NCTC13184_06982, | 60/81 | SUA48430.1 |
|
| 182 | sugar O-acetyltransferase | E1091_12580, | 64/72 | TDB92781.1 |
|
| 304 | LysR family transcriptional regulator | AFR_16085, | 57/69 | AGZ41499.1 |
|
| 104 | transposase | CLV43_10550, | 56/61 | PRY41292.1 |
Figure 3Proposed biosynthetic pathway of dnacin B1. The biosynthetic pathway of assumed precursor 3-OH-PAPA was presented in red dotted box.
Figure 4Heterologous expression of PAPA in E. coli BL21 (DE3). (A) Schematic representation of PAPA synthesis in engineered E. coli strain HXJE03. Genes dinV, dinE and dinF were all expressed under the control of T7 promoter. (B) HPLC-MS analysis of PAPA standard and the products of engineered E. coli strains (HXJE03 and HXJE04). (C) HR-ESI-MS analysis result of PAPA.
Figure 5Expression and characterization of APATs and TyrB. (A) SDS-PAGE of nine purified APATs and TyrB expressed in E. coli BL21 (DE3). (B) Conversion rate analysis of recombinant nine APATs and TyrB in vitro. (C) The proposed reversible reactions of APATs and TyrB.